1. Home
  2. Stock quotes
  3. Adamas Pharmaceuticals, Inc.
  4. Financial Statements
  5. Balance Sheet
  6. Deferred Revenue
Adamas Pharmaceuticals, Inc. logo
Adamas Pharmaceuticals, Inc. ADMS
$ 8.22 0.0%
mail-toReport an Error

Adamas Pharmaceuticals, Inc. Deferred Revenue 2011-2024 | ADMS

Annual Deferred Revenue Adamas Pharmaceuticals, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - - - - - 29.6 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
29.6 M 29.6 M 29.6 M